Segall Bryant & Hamill LLC Has $11.08 Million Stock Position in Innospec Inc. (NASDAQ:IOSP)

Segall Bryant & Hamill LLC grew its holdings in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) by 18.8% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 100,675 shares of the specialty chemicals company's stock after acquiring an additional 15,925 shares during the quarter. Segall Bryant & Hamill LLC owned about 0.40% of Innospec worth $11,080,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of IOSP. PNC Financial Services Group Inc. lifted its holdings in Innospec by 8.8% in the fourth quarter. PNC Financial Services Group Inc. now owns 1,868 shares of the specialty chemicals company's stock worth $206,000 after purchasing an additional 151 shares during the period. HighTower Advisors LLC raised its position in shares of Innospec by 5.2% during the 3rd quarter. HighTower Advisors LLC now owns 3,103 shares of the specialty chemicals company's stock worth $350,000 after buying an additional 154 shares in the last quarter. Raymond James Trust N.A. lifted its stake in shares of Innospec by 7.9% in the 3rd quarter. Raymond James Trust N.A. now owns 2,106 shares of the specialty chemicals company's stock worth $238,000 after acquiring an additional 155 shares during the period. New York State Teachers Retirement System boosted its holdings in shares of Innospec by 1.4% in the fourth quarter. New York State Teachers Retirement System now owns 14,981 shares of the specialty chemicals company's stock valued at $1,649,000 after acquiring an additional 200 shares in the last quarter. Finally, Inspire Advisors LLC increased its stake in shares of Innospec by 3.3% during the fourth quarter. Inspire Advisors LLC now owns 6,704 shares of the specialty chemicals company's stock valued at $738,000 after acquiring an additional 213 shares during the period. Institutional investors own 96.64% of the company's stock.

Insider Buying and Selling at Innospec

In related news, SVP Corbin Barnes sold 598 shares of Innospec stock in a transaction on Monday, February 24th. The stock was sold at an average price of $103.06, for a total value of $61,629.88. Following the transaction, the senior vice president now directly owns 8,051 shares in the company, valued at $829,736.06. The trade was a 6.91 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Milton C. Blackmore sold 652 shares of the business's stock in a transaction on Friday, February 21st. The stock was sold at an average price of $103.30, for a total value of $67,351.60. Following the sale, the director now directly owns 8,376 shares in the company, valued at $865,240.80. This trade represents a 7.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 7,696 shares of company stock valued at $794,853. Corporate insiders own 1.52% of the company's stock.

Innospec Trading Down 2.2 %

NASDAQ:IOSP traded down $2.19 during mid-day trading on Friday, reaching $95.20. 123,563 shares of the stock were exchanged, compared to its average volume of 139,220. The business has a fifty day moving average price of $105.47 and a 200 day moving average price of $110.55. Innospec Inc. has a 1-year low of $94.77 and a 1-year high of $133.71. The firm has a market capitalization of $2.38 billion, a PE ratio of 67.04 and a beta of 1.08.

Innospec (NASDAQ:IOSP - Get Free Report) last announced its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.05. Innospec had a net margin of 1.93% and a return on equity of 12.27%. The company had revenue of $466.80 million for the quarter, compared to analysts' expectations of $447.43 million. On average, sell-side analysts forecast that Innospec Inc. will post 6.18 earnings per share for the current year.

Innospec declared that its board has authorized a stock repurchase program on Monday, March 10th that permits the company to repurchase $50.00 million in outstanding shares. This repurchase authorization permits the specialty chemicals company to purchase up to 2% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's board of directors believes its stock is undervalued.

Analysts Set New Price Targets

Separately, StockNews.com upgraded Innospec from a "hold" rating to a "buy" rating in a research report on Monday, March 24th.

Innospec Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.